Notes
Outline
IT for Healthcare: Why is it taking so long?
NIST Workshop
Barriers to Implementation
RS Johannes, MD, MS
Story of Scurvy
Once terribly important: 100 of 160 of Vasco de  Gama’s crew died of it on the Cape of Good Hope voyage.
James Lancaster:  Gave lemon juice to seamen on one of four ships on voyage to India.  Most remained healthy but he lost 110 of 278 seamen on other three ships.
James Lind: British naval physician.  Usually credited with having done the first clinical trial.  Scurvy patients were assigned 1 of 5 treatment groups.  He produced objective evidence that the citrus fruit subgroup improved.
British Navy adopts citrus fruits for long voyages.
British Merchant Marine adopts same policy.
The History  of Scurvy
Personal Context
1978: Chief Resident, Osler Medical Service, Johns Hopkins Hospital.
1979: Implemented HOPS adapted from Bill Stead’s System at Duke University.
1990: Left Johns Hopkins to join a startup dedicated to solving the structured medical document problem.
1994 & 1997: Successfully competed for 2 NIST ATP Grants.
NIST ATP Program
Windows based component for “posting codified patient data to a repository via automation of the process of clinical note writing.”
MedEncode project was piloted at Brigham & Women’s hospital.
70% of clinical abstracts submitted to AGA since 1995 have used data from GIstation
Distribution rights were sold to Olympus America
Over 350 (~10% of endoscopy centers) were installed
Olympus ImageManager
Recent Context
Joined Cardinal MediQual in August of 2000
MediQual is a Cardinal company that does health services and outcomes research for acute care settings
Pioneered one of the first successful methodologies to perform risk adjustment for reporting performance measures in acute care settings
The methods involve use of clinical data to attain physician acceptance and higher precision
Support Pennsylvania Health Care Cost Containment Council (PHC4)
PHC4
Has 15 years of publically reporting performance measures across all hospitals in Pennsylvania.
Is the only state with such a track record.
Uses the clinically based MediQual methodology.
Relies on Key Clinical Findings (KCFs):
Ejection Fraction
Presence on admission of pleural effusions or ascites
Glasgow Coma score
Vital signs
Laboratory data
The Importance of Clinical Data
“Administrative data cannot account for differences in severity of illness with any degree of clinical subtlety.”
Mark R. Chassin
NEJM, August 30, 2001
“Risk models based upon administrative data can lead to substantial misclassification of hospitals when compared with models based upon higher-quality data.”
Harlan M Krumholz
JAMA, March 13, 2002
PHC4
Has 15 years of publically reporting performance measures across all hospitals in Pennsylvania.
Is the only state with such a track record.
Uses the clinically based MediQual methodology.
Relies on Key Clinical Findings (KCFs):
Ejection Fraction
Presence on admission of pleural effusions or ascites
Glasgow Coma score
Vital signs
Laboratory data
Clinical Data Remains Hard to Come by
UB92 data is available electronically
An electronic feed for laboratory data has been available for several years.  To date, less than 20% of hospitals avail them selves of it.  The rest abstract.
Pharmacy data is just now beginning to be available electronically and the heterogeneity of pharmacy system data is shocking.
No hospital provides vital signs electronically.
Other KCFs are abstracted from the medical record.
Barriers to Implementation
1998 American College of Gastroenterology Meeting
Timing of EMRs
I had a four year old set of slides
I also reviewed several articles on the subject
The European Experience
Gerry O’Conner & NNE
Everett M. Rogers “S-shaped Curve”
The European Experience
Origins of the “S-shaped Curve”
The innovation-decision process
Who Drives This Process
Not the innovators!
Early adopters
Great peer respect
Must be consistently correct
Early majority
A full 1/3 of eventual users
Much peer group interaction
Seldom opinion leaders
Often have a long deliberation period
The Roger’s Model
Homophily
Communication between like individuals
Much communication is like this since it is often highly effective communication
Can act as an “invisible barrier to the flow of innovations”
Given a high degree of homophily the “in the know” interact primarily with themselves and impede the flow of information
State of the Art
This process has and will continue to take more time than one might wish
Rapid growth in this area is possible
Key barriers remain
Absence of an universal patient identifier
Continued separation of clinical and administrative systems
Continued separation of hospital and ambulatory systems
Clear elucidation and understanding of benefits
Other Important Points
Clement McDonald: JAMIA 1997
Importance of standards
Too many different separate systems with different data structures
Diversity of kinds of sites of care
Optimistic about Kassebaum-Kennedy Bill
Kevin Johnson: Arch Pediat Adolesc Med 2002
Knapp categorization (Situational; Cognitive; Liability; Knowledge)
Highlighted knowledge and attitudinal barriers
IT costs
Unproven return on investment
Is Now the Time?
Yes…but,
You can not all of what you might want today
You will be an early adopter
You must set realistic expectations and goals
You will find yourself ahead of the curve in 2-3 years
You will have setbacks
You must document the benefits
You should share the results of documented benefits
You must have strong internal leadership and institutional will
Perhaps the Timing is Good
Market is looking for a growth sector
Medical costs continue to rise
Calls for data are coming from everywhere
Importance of clinical research is both being demonstrated and called into question
HIPAA is around the corner
NIST ATP has a proven record in technology transfer
It Will Be Worth the Wait!